Hvivo PLC (LON:HVO) insider Jaime Ellertson bought 16,401 shares of Hvivo stock in a transaction on Monday, January 8th. The stock was acquired at an average price of GBX 55 ($0.75) per share, for a total transaction of £9,020.55 ($12,232.91).
Hvivo PLC (HVO) opened at GBX 54.50 ($0.74) on Thursday. The company has a market capitalization of $23.13 and a price-to-earnings ratio of -272.50. Hvivo PLC has a 52 week low of GBX 50 ($0.68) and a 52 week high of GBX 239.75 ($3.25).
Separately, Numis Securities lowered Hvivo to a “hold” rating and set a GBX 80 ($1.08) price target on the stock. in a research note on Thursday, September 21st.
WARNING: This story was originally posted by Community Financial News and is the property of of Community Financial News. If you are viewing this story on another domain, it was illegally stolen and republished in violation of United States and international trademark & copyright law. The correct version of this story can be viewed at https://www.com-unik.info/2018/01/11/hvivo-plc-hvo-insider-jaime-ellertson-purchases-16401-shares.html.
hVIVO plc, formerly Retroscreen Virology Group plc, is a holding company. The Company is engaged in a life sciences business pioneering a technology platform of human disease models to accelerate drug discovery and development in respiratory and infectious diseases, including flu, respiratory syncytial virus (RSV), asthma and common cold.
What are top analysts saying about Hvivo? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Hvivo and related companies.